November / December 2019
Features
First results of gene and cell therapies for nAMD, RP, plus ...
Findings on predictors of endophthalmitis, widefield OCT-A vs. FA and microsecond pulsing laser make five worthy takeaways.
IOP and anti-VEGF drugs: What we know so far
Chronic changes in intraocular pressure may be dependent on the anti-VEGF drug used. A look at emerging research on physiology and the role of genetics.
Retinal imaging and neurodegenerative disease
A review of retinal changes and potential biomarkers in Alzheimer’s, Huntington’s and Parkinson’s diseases.
Clearing up the language of retinal imaging
A review of the International Widefield Imaging Study Group recommendations for a terminology to describe image captures from various modalities.
Personalized medicine and retinoblastoma treatment
Globe-salvaging therapies are minimizing the need for enucleation for the most common primary intraocular malignancy of childhood.
Departments
Clinical Trial Closeup
Potential of KSI-301 to extend treatment
The latest results reported efficacy up to five months after the last loading dose.
Coding Commentary
Coding for surgery in the postop period
How to use modifiers 58, 78 and 79 for a planned or unplanned trip back to the OR.
Editor's Page
News
Retina Rounds
Melanoma? Or pseudomelanoma?
A patient develops two rare lesions in the same eye.
Surgical Pearl Video
Never use two steps when one will do
Step-saving tips when isolating rectus muscles and performing membrane peeling.
Refractory optic pit maculopathy surgery
This approach for this challenging operation uses an internal limiting membrane flap as a ‘plug.’
Current Issue
Continuing Medical Education
Additional Publications
Learn More about Stargardt Disease
Watch the webinar
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
Improving Wet AMD Outcomes With a Fellow Eye Strategy
